Login / Signup

Associations between metabolic hyperferritinaemia, fibrosis-promoting alleles and clinical outcomes in steatotic liver disease.

Deepika SureshAshley LiMatthew J MillerKarn WijarnpreechaVincent L Chen
Published in: Liver international : official journal of the International Association for the Study of the Liver (2023)
In MASLD patients, metabolic hyperferritinaemia was associated with increased mortality and higher incidence of liver-related events, and cirrhosis-promoting alleles but not with iron overload-promoting HFE mutations.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • risk factors
  • newly diagnosed
  • prognostic factors
  • type diabetes
  • cardiovascular disease
  • patient reported